ASP Isotopes (NASDAQ:ASPI) Posts Quarterly Earnings Results, Misses Expectations By $0.11 EPS

Key Points

• ASP Isotopes reported a quarterly loss of $0.28 per share, missing analysts’ consensus estimate of a $0.17 loss by $0.11. The company posted a negative net margin of 644.40% and negative return on equity of 112.46%.
• Shares fell 0.2% to $4.27, near the lower end of their 52-week range of $3.51 to $14.49. Analysts have an average “Hold” rating and a $13.00 price target, while Weiss Ratings maintained a “sell (D-)” rating.
• Insiders sold 279,079 shares worth approximately $2.05 million over the past three months, primarily to cover tax withholding obligations tied to equity awards. Institutional investors own 16.80% of the stock.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) issued its earnings results on Friday. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by ($0.11), Zacks reports. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

ASP Isotopes Stock Down 0.2%

ASPI stock traded down $0.01 during midday trading on Friday, reaching $4.27. 1,941,410 shares of the company's stock traded hands, compared to its average volume of 4,927,466. The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69. The firm's fifty day moving average price is $5.23 and its 200-day moving average price is $5.44. ASP Isotopes has a 52 week low of $3.51 and a 52 week high of $14.49. The company has a market cap of $654.63 million, a price-to-earnings ratio of -2.05 and a beta of 3.61.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $13.00.

Insider Transactions at ASP Isotopes

In related news, COO Robert Ainscow sold 8,438 shares of the company's stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $7.00, for a total value of $59,066.00. Following the sale, the chief operating officer owned 2,281,879 shares in the company, valued at $15,973,153. This represents a 0.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Elliot Mann sold 83,759 shares of the firm's stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $7.76, for a total transaction of $649,969.84. Following the completion of the transaction, the chief executive officer directly owned 9,579,845 shares in the company, valued at approximately $74,339,597.20. The trade was a 0.87% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 279,079 shares of company stock valued at $2,049,208. Corporate insiders own 14.40% of the company's stock.

Institutional Trading of ASP Isotopes

Several institutional investors and hedge funds have recently modified their holdings of ASPI. Quantbot Technologies LP bought a new position in shares of ASP Isotopes in the third quarter valued at approximately $34,000. BNP Paribas Financial Markets grew its holdings in ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company's stock worth $41,000 after buying an additional 2,548 shares in the last quarter. Guggenheim Capital LLC purchased a new stake in ASP Isotopes in the 4th quarter valued at $72,000. Caption Management LLC boosted its holdings in ASP Isotopes by 110.5% during the fourth quarter. Caption Management LLC now owns 13,800 shares of the company's stock worth $74,000 after purchasing an additional 145,800 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC purchased a new position in ASP Isotopes during the fourth quarter worth about $74,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source